Medifast Inc Stock Filter Stocks by Fundamentals
MED Stock | USD 37.53 0.46 1.24% |
MEDIFAST INC fundamentals help investors to digest information that contributes to MEDIFAST INC's financial success or failures. It also enables traders to predict the movement of MEDIFAST Stock. The fundamental analysis module provides a way to measure MEDIFAST INC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MEDIFAST INC stock.
MEDIFAST | Debt to Equity |
MEDIFAST Debt to Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 1.1B | 775.9M | 814.6M | Total Revenue | 1.5B | 1.6B | 1.1B | 1.1B |
MEDIFAST Debt to Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for MEDIFAST INC is extremely important. It helps to project a fair market value of MEDIFAST Stock properly, considering its historical fundamentals such as Debt to Equity. Since MEDIFAST INC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MEDIFAST INC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MEDIFAST INC's interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
MEDIFAST Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, MEDIFAST INC has a Debt to Equity of 0.0null. This indicator is about the same for the Personal Care Products average (which is currently at 0.0) sector and about the same as Debt to Equity (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
MEDIFAST Fundamentals
Return On Equity | 0.56 | ||||
Return On Asset | 0.25 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 275.87 M | ||||
Shares Outstanding | 10.9 M | ||||
Shares Owned By Insiders | 2.70 % | ||||
Shares Owned By Institutions | 97.82 % | ||||
Number Of Shares Shorted | 1.94 M | ||||
Price To Earning | 13.99 X | ||||
Price To Book | 2.00 X | ||||
Price To Sales | 0.38 X | ||||
Revenue | 1.07 B | ||||
Gross Profit | 1.14 B | ||||
EBITDA | 139.51 M | ||||
Net Income | 99.42 M | ||||
Cash And Equivalents | 87.69 M | ||||
Cash Per Share | 5.57 X | ||||
Total Debt | 22.01 M | ||||
Debt To Equity | 0.43 % | ||||
Current Ratio | 1.29 X | ||||
Book Value Per Share | 18.69 X | ||||
Cash Flow From Operations | 147.66 M | ||||
Short Ratio | 5.47 X | ||||
Earnings Per Share | 9.10 X | ||||
Price To Earnings To Growth | 1.95 X | ||||
Target Price | 37.5 | ||||
Number Of Employees | 634 | ||||
Beta | 1.18 | ||||
Market Capitalization | 408.91 M | ||||
Total Asset | 309.91 M | ||||
Retained Earnings | 174.65 M | ||||
Working Capital | 131.73 M | ||||
Current Asset | 88.07 M | ||||
Current Liabilities | 23.56 M | ||||
Z Score | 17.39 | ||||
Annual Yield | 0.18 % | ||||
Five Year Return | 2.53 % | ||||
Net Asset | 309.91 M | ||||
Last Dividend Paid | 4.95 |
About MEDIFAST INC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MEDIFAST INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEDIFAST INC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEDIFAST INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. Medifast operates under Personal Services classification in the United States and is traded on New York Stock Exchange. It employs 984 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out MEDIFAST INC Piotroski F Score and MEDIFAST INC Altman Z Score analysis. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.